Heterogeneity of Breast Cancer Genomes: Going Beyond Therapy to Risk Assessment and Prevention
Cancer Genomics Consortium via YouTube
MIT Sloan: Lead AI Adoption Across Your Organization — Not Just Pilot It
Learn Generative AI, Prompt Engineering, and LLMs for Free
Overview
Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
Explore the complexities of breast cancer genomics in this keynote presentation from the Cancer Genomics Consortium (CGC) 2023 Annual Meeting. Delve into the heterogeneity of breast cancer genomes, moving beyond therapy to focus on risk assessment and prevention strategies. Listen as Dr. Olufunmilayo Olopade, introduced by Gordana Raca, shares insights on cutting-edge research and its implications for patient care. Gain valuable knowledge about clinical cancer genomics, accurate diagnosis of underlying genomic alterations, and the potential for personalized treatment approaches. Discover how the Cancer Genomics Consortium is working towards ensuring all cancer patients receive the most appropriate therapy based on their genomic profile.
Syllabus
CGC 2023 Keynote Presentation - Heterogeneity of breast cancer genomes
Taught by
Cancer Genomics Consortium